Ratings for Cooper Companies (NASDAQ:COO) were provided by 6 analysts in the past three months, showcasing a mix of bullish and bearish perspectives.
In the table below, you'll find a summary of their recent ratings, revealing the shifting sentiments over the past 30 days and comparing them to the previous months.
| Bullish | Somewhat Bullish | Indifferent | Somewhat Bearish | Bearish | |
|---|---|---|---|---|---|
| Total Ratings | 2 | 1 | 2 | 0 | 1 |
| Last 30D | 1 | 0 | 0 | 0 | 0 |
| 1M Ago | 0 | 0 | 0 | 0 | 0 |
| 2M Ago | 1 | 1 | 0 | 0 | 0 |
| 3M Ago | 0 | 0 | 2 | 0 | 1 |
In the assessment of 12-month price targets, analysts unveil insights for Cooper Companies, presenting an average target of $90.0, a high estimate of $101.00, and a low estimate of $71.00. This upward trend is apparent, with the current average reflecting a 6.3% increase from the previous average price target of $84.67.
Exploring Analyst Ratings: An In-Depth Overview
An in-depth analysis of recent analyst actions unveils how financial experts perceive Cooper Companies. The following summary outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
| Analyst | Analyst Firm | Action Taken | Rating | Current Price Target | Prior Price Target |
|---|---|---|---|---|---|
| David Saxon | Needham | Raises | Buy | $101.00 | $99.00 |
| David Saxon | Needham | Lowers | Buy | $99.00 | $100.00 |
| Matt Miksic | Barclays | Raises | Overweight | $98.00 | $97.00 |
| Joanne Wuensch | Citigroup | Raises | Neutral | $88.00 | $72.00 |
| Patrick Wood | Morgan Stanley | Raises | Equal-Weight | $83.00 | $76.00 |
| David Roman | Goldman Sachs | Raises | Sell | $71.00 | $64.00 |
Key Insights:
- Action Taken: Analysts frequently update their recommendations based on evolving market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to Cooper Companies. This information provides a snapshot of how analysts perceive the current state of the company.
- Rating: Unveiling insights, analysts deliver qualitative insights into stock performance, from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of Cooper Companies compared to the broader market.
- Price Targets: Gaining insights, analysts provide estimates for the future value of Cooper Companies's stock. This comparison reveals trends in analysts' expectations over time.
To gain a panoramic view of Cooper Companies's market performance, explore these analyst evaluations alongside essential financial indicators. Stay informed and make judicious decisions using our Ratings Table.
Stay up to date on Cooper Companies analyst ratings.
About Cooper Companies
CooperCompanies is one of the largest eyecare companies in the US. It operates in two segments: CooperVision and CooperSurgical. CooperVision is a pure-play contact lens business with a suite of spherical, multifocal, and toric contact lenses. The company also has one of the most comprehensive specialty lens portfolios in the world. With brands including Proclear, Biofinity, MyDay, and Clariti, Cooper controls roughly one fourth of the US contact lens market. CooperSurgical, founded in 1990, is made up of equipment related to reproductive care, fertility, and women's care. Cooper has the broadest medical device coverage of the entire IVF cycle. It also has Paragard, the only hormone-free IUD in the US, and controls 17% of the US IUD market.
A Deep Dive into Cooper Companies's Financials
Market Capitalization: Boasting an elevated market capitalization, the company surpasses industry averages. This signals substantial size and strong market recognition.
Revenue Growth: Over the 3M period, Cooper Companies showcased positive performance, achieving a revenue growth rate of 4.59% as of 31 October, 2025. This reflects a substantial increase in the company's top-line earnings. When compared to others in the Health Care sector, the company excelled with a growth rate higher than the average among peers.
Net Margin: Cooper Companies's net margin excels beyond industry benchmarks, reaching 7.94%. This signifies efficient cost management and strong financial health.
Return on Equity (ROE): Cooper Companies's ROE lags behind industry averages, suggesting challenges in maximizing returns on equity capital. With an ROE of 1.02%, the company may face hurdles in achieving optimal financial performance.
Return on Assets (ROA): Cooper Companies's ROA stands out, surpassing industry averages. With an impressive ROA of 0.68%, the company demonstrates effective utilization of assets and strong financial performance.
Debt Management: Cooper Companies's debt-to-equity ratio is below the industry average at 0.3, reflecting a lower dependency on debt financing and a more conservative financial approach.
The Basics of Analyst Ratings
Ratings come from analysts, or specialists within banking and financial systems that report for specific stocks or defined sectors (typically once per quarter for each stock). Analysts usually derive their information from company conference calls and meetings, financial statements, and conversations with important insiders to reach their decisions.
In addition to their assessments, some analysts extend their insights by offering predictions for key metrics such as earnings, revenue, and growth estimates. This supplementary information provides further guidance for traders. It is crucial to recognize that, despite their specialization, analysts are human and can only provide forecasts based on their beliefs.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
Login to comment